Immunic, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $127.1M | $86.9M |
| FY2022 | — | $113.7M | $106.7M |
| FY2023 | — | $28.9M | $46.7M |
| FY2024 | — | $18.4M | $35.7M |
| FY2025 | — | $-6.7M | $15.5M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $127.1M | $86.9M |
| FY2022 | — | $113.7M | $106.7M |
| FY2023 | — | $28.9M | $46.7M |
| FY2024 | — | $18.4M | $35.7M |
| FY2025 | — | $-6.7M | $15.5M |